Member Info for hasiba

I could not buy from 4.15...
Well it seems the MMs have been left to find sellers but not many there!
Good turning point and hope to see sp better tomorrow as MMs will have to raise bid price to lure sellers....

At 10.19p

Added at 4.07p leveraging up...

C7...I haven’t bought any today but looks like I have a competition!

..very well around 10.75p then hopefully up she goes....

RP...yes and this will lead to other companies producing variety of vaccines accordingly and every now and again they may face a similar situation ...
Sclp approach is very clever ....and no wonder those hedge funds are fighting for a bigger slice..
I was mainly focusing on anti cancer immunotherapy and covidity was more like add on but with today news the playing field has widened...
I might put the garden shed on ebay tomorrow to get more of sclp! ...lol

If it’s a mutation then this can be less problematic as they can adjust the current vaccine or the existing vaccine works well too but maybe less efficacy by a small margins...but still good..
But if it’s a new variety not Covid19 then we are in a bigger problem.
In either scenario we are going to need many Companies to produce the vaccines..for years to come..
Things will be clearer in time ...

The calm before the stormy spike...
Confident holding here

Topped up at 10.755p
GL

Good RNS complimenting other accumulating purchases ....this will help to underpin the SP...

Violindog.....
Yes I have holding in AFC and other fuel technology companies and hydrogen for a while and didn’t they do well! Also invested in Zoe (cannabis producer) but sold recently...
GL with your investments

RR.....no screaming tantrums....
Didn’t realise you have been in sclp 12 years...that is quite unfortunate!
I never stay that long...
Timing can be very tricky...
Anyway GL and enjoy reading your posts..

RR...
Good morning
Any positive progress ...data takes time perhaps 6-12 months
But news of collaboration,partnerships, selling one of products, directors buys,ii increasing holdings..etc
Any will spike the sp..
but hey imo time to load on dips while the opportunity of cheap shares exists..
Dyor as always
Holding strong

C7...good morning
Our sclp is solid with a very strong balance sheet with a current ratio of 4.77....and the management needs to work it efficiently .with the calibre we have of Scientists and hedge funds..I have no doubt Mr market will wake up to realise they have missed our real value and huge potentials.
Confident and holding strong and will keep accumulating on the dips for now..
GL

Correction “ sold for a song by”
Should read (bought for a song by)

GN everyone ,great discussions and opinions by all..

rshah.....that is the best of today’s posts....let’s live in hope ...
Well done...talented

“if the company failed to commercialse the IP for whstever reason.”
Then it will go bust or at the best it hopes for to become cash shell and will be sold for a song by another private company cheaply and to list on the market faster....and near 00 benefit to shareholders us.
IP has no intrinsic value in commercially failed companies...end off.
It has value in a viable developing company of its IP...
This imv

I don’t believe there is any added therapeutic value for Redmile to pay for Intellectual Property of sclp if it showed trial failure in other products...
And there is no proof that the Intellectual Property would be better than existing therapy....so what is the point and benefit for Redmile to preserve Intellectual Property in such uncertainty of other sclp products....
Trial successes and farming out in collaboration and partnerships the one clear path for all stakeholders to focus on....
Redmile would be naive to inject cash for the purpose of preserving intellectual property ..
Just imo

All depends on the incoming update and what have they achieved or hoping to chief based on positive results on different plans/strategy that were stated in Sept..
Then we are waiting for the definitive detailed technical report in Q1 2020 as stated too...that may give us far better estimate than the interims worse scenario declared previously..
With regards to the bonds...I can’t see a problem here as long as Hur is producing and making enough fcf to manage the bonds in July 2022.....oil price and good productivity are paramount here.
Hur has many options to explore and mitigation of water cut hopefully continues to be under control...
Over all I remain optimistic but mindful of the history of Hur under the previous ceo ...and more optimistic with the new team...
Let’s hope all is well.
Holding strong
GL

Ivy
I respectfully disagree that sclp can do much to advance without Redmile giving the node. Redmile will move us forwards in many ways as indicated in my latest post and our scientists do the hard work. Money talks !
Redmile will control sclp and will buy far more and take over sclp destiny or farming out but not in. Redmile and Vulpes are now working together and us are in minority ,they hold most cards. No way sclp could have moved forwards without them...and sp would have declined to a few pennies.
Currently sclp still is not cash rich to do works with all products as the money is not enough even for phase2 trials
Each of these trials costs at least $9-10m.At best they maybe able to manage one or max two products by the time you pay all other costs including salaries.
They needs big Pharmas collaborations and partnerships.
The funds given to them lately is the start and not the end deal. Far more to come and this is always what Redmile does ultimately takes control. They want profit now and not in years to come and so am I !
GL and times will tell.